These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10293974)

  • 1. Implementation of an intravenous potassium policy.
    Cooper BE
    Hosp Pharm; 1989 Jun; 24(6):462-4. PubMed ID: 10293974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An intravenous potassium policy with concurrent physician evaluation.
    Closson RG; Eckhardt K
    Hosp Pharm; 1990 Jul; 25(7):662-4. PubMed ID: 10105332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of a once-daily aminoglycoside program in a large community-teaching hospital.
    Nicolau DP; Belliveau PP; Nightingale CH; Quintiliani R; Freeman CD
    Hosp Pharm; 1995 Aug; 30(8):674-6, 679-80. PubMed ID: 10144645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous admixture workload in a critical care pharmacy satellite.
    O'Brodovich M; Blain L
    Can J Hosp Pharm; 1992 Apr; 45(2):67-8. PubMed ID: 10117970
    [No Abstract]   [Full Text] [Related]  

  • 5. IV push policy: the economic effects of IV drug administration guidelines.
    Hughes TE; Suzuki NT
    Hosp Formul; 1986 Jul; 21(7):793-9, 802. PubMed ID: 10317755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achieving rational therapeutics through consensus-based protocols and follow-up.
    Quintiliani R; Gousse GC; Chow MS
    Hosp Formul; 1990 Mar; 25(3):283-4, 289-94. PubMed ID: 10103836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an institutional i.v. drug delivery policy.
    Piecoro JJ
    Am J Hosp Pharm; 1987 Nov; 44(11):2557-9. PubMed ID: 3687995
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravenous admixture service: implementation of service in a complex ICU patient population.
    Roof PS
    Hosp Pharm; 1989 Aug; 24(8):633-6, 638. PubMed ID: 10294359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost containment through P & T committee drug utilization review.
    Bender FH; DeMatteo CS
    Hosp Formul; 1984 Aug; 19(8):699-700, 705-7. PubMed ID: 10267391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of a safer approach to intravenous drug infusions: failure mode effects analysis.
    Apkon M; Leonard J; Probst L; DeLizio L; Vitale R
    Qual Saf Health Care; 2004 Aug; 13(4):265-71. PubMed ID: 15289629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What makes patients safer? Simplicity, standardization succeed in heparin program.
    Clin Resour Manag; 2000 Nov; 1(11):166-8. PubMed ID: 11129348
    [No Abstract]   [Full Text] [Related]  

  • 12. Reducing i.v. waste to under 2.25 percent.
    Newhouse JG; Paul VM; Waugh NA; Frye CB
    Hosp Pharm; 1988 Mar; 23(3):241-2, 246-7. PubMed ID: 10312459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development and implementation of a drug utilization review program.
    Lazor-Bajcar JM; Fowler R
    Can J Hosp Pharm; 1988 Feb; 41(1):11-6. PubMed ID: 10286608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolving concerns of pharmacy and therapeutics committees.
    Weintraub M
    Hosp Formul; 1980 Jan; 15(1):29-31. PubMed ID: 10244955
    [No Abstract]   [Full Text] [Related]  

  • 15. A multidisciplinary approach to patient controlled analgesia.
    Michael KA; Jozefczyk KG; Nelson RP; Linn P; Fogle P; Wise J
    Hosp Pharm; 1989 Oct; 24(10):829-34. PubMed ID: 10295900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Productivity and quality assessment associated with conversion from i.v. to oral ranitidine.
    Baciewicz AM; Cowan RI
    Hosp Formul; 1993 Apr; 28(4):397-8. PubMed ID: 10125324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspectives on Drug and Therapeutics Committee policy implementation.
    Tan EL; Day RO; Brien JA
    Res Social Adm Pharm; 2005 Dec; 1(4):526-45. PubMed ID: 17138494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug usage evaluation of warfarin sodium: the need for improved patient education.
    Hartwig SC
    Hosp Formul; 1992 Mar; 27(3):287-8, 300, 302. PubMed ID: 10116495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing adverse events in the pediatric intensive care unit: prospectively targeting factors that lead to intravenous potassium chloride order errors.
    White JR; Veltri MA; Fackler JC
    Pediatr Crit Care Med; 2005 Jan; 6(1):25-32. PubMed ID: 15636655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug stability guidelines for a continuous infusion chemotherapy program.
    Vyas HM; Baptista RJ; Mitrano FP; Sesin GP
    Hosp Pharm; 1987 Jul; 22(7):685-7. PubMed ID: 10282686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.